EyePoint Pharmaceuticals, Inc.

NASDAQ:EYPT

Biotechnology

Healthcare
$2.99 +1.98%

+$0.26 today

Market cap
$250.69M
Beta
1.75
P/E (TTM)
-4.2
EPS (TTM)
-$3.16
52W Low $7.94High $19.11

Volume 2.75M

Average 0.95M

Balance Sheet

Inspect the capital base behind the business.

Assets

$364.00M

FY 2025 · Annual

-13.0% YoY

Liabilities

$57.88M

FY 2025 · Annual

-29.4% YoY

Equity

$306.11M

FY 2025 · Annual

-9.0% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents178.59M95.63M281.26M99.7M101.82M
Short-term Investments32.97M48.93M49.79M271.21M204.27M
Net Receivables18.35M15.5M805K607K651K
Inventory3.62M2.89M3.91M2.31M1.81M
Other Current Assets517K782K1.01M1.41M20.11M
Total Current Assets237.75M172.81M344.8M383.31M328.66M
Property, Plant & Equipment (Net)2.73M7.4M10.23M29.18M20.22M
Goodwill00000
Intangible Assets22.75M0000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets150K150K150K5.98M15.12M
Total Non-current Assets25.63M7.55M10.38M35.16M35.34M
Total Assets263.37M180.36M355.18M418.47M364M
Account Payables7.39M5.92M6.5M11.72M10.49M
Short-term Debt010.48M000
Tax Payables00000
Deferred Revenue1.07M1.21M38.59M17.78M0
Other Current Liabilities7.32M9.52M13.28M13.27M16.67M
Total Current Liabilities23.66M34.54M63.26M49.05M37.02M
Long-term Debt36.56M29.31M000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)14.56M13.56M20.69M10.85M0
Other Non-current Liabilities2.35M600K0205K87K
Total Non-current Liabilities55.33M49.45M25.6M32.92M20.86M
Total Liabilities78.99M83.99M88.86M81.96M57.88M
Common Stock34K34K49K68K83K
Retained Earnings(569.1M)(671.35M)(742.15M)(873.02M)(1.1B)
Accumulated OCI841K786K864K1.03M961K
Other Stockholders Equity00000
Minority Interest00000
Total Equity184.38M96.37M266.32M336.5M306.11M
Total Debt39.2M46.35M4.91M21.86M20.77M
Net Debt(139.39M)(49.29M)(276.36M)(77.85M)(81.05M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$77.7M
Short-term Investments$144.8M
Receivables$1.2M
Inventory$1.3M
Other Current$24.6M
Total Current Assets$249.5M
PP&E (Net)$19.8M
Other Non-current$18.9M
Total Non-current Assets$38.7M
Total Assets$288.2M

Analysis

Selected assets total $288.2M for Latest. The largest visible component is Short-term Investments at $144.8M, about 50.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingOct 7, 2026
8-KCurrent reportSep 10, 2026
SC 13GSC 13G filingSep 8, 2026
4Statement of changes in beneficial ownershipAug 24, 2026
4Statement of changes in beneficial ownershipAug 18, 2026

How much cash does EYPT have?

EyePoint Pharmaceuticals, Inc. (EYPT) reported $101.82M in cash and equivalents in fiscal 2025.

How much debt does EYPT carry?

EyePoint Pharmaceuticals, Inc. (EYPT) reported $20.77M of total debt, with net debt of -$81.05M.